Ommoleila Molavi (Leila Hatami-Baroogh)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

BioImpacts : BI

Molecular neurobiology

Oxidative medicine and cellular longevity

Cellular and molecular life sciences : CMLS

University of Alberta

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alberta Oct 01 2009 - Jul 01 2014

Canada

PostDoc :: Lab Medicine and Pathology

Education History

University of Alberta Jan 02 2005 - Oct 12 2009

Canada

PHD :: Pharmacy and Pharmaceutical Sciences

Publications

Mina Mohammadinasr, Soheila Montazersaheb, Hormoz Ayromlou, Vahid Hosseini, Ommoleila Molavi, Mohammad Saeid Hejazi
Exosome Content-Mediated Signaling Pathways in Multiple Sclerosis. Molecular neurobiology 61 (8) (2024)
Mina Mohammadinasr, Soheila Montazersaheb, Hormoz Ayromlou, Vahid Hosseini, Ommoleila Molavi, Mohammad Saeid Hejazi
Exosome Content-Mediated Signaling Pathways in Multiple Sclerosis. Molecular neurobiology (2024)
Mina Mohammadinasr, Soheila Montazersaheb, Ommoleila Molavi, Houman Kahroba, Mahnaz Talebi, Hormoz Ayromlou, Mohammad Saeid Hejazi
Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers. Neuromolecular medicine (2023)
Raheleh Farahzadi, Mohammad Saeid Hejazi, Ommoleila Molavi, Elahe Pishgahzadeh, Soheila Montazersaheb, Sevda Jafari
Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation. Oxidative medicine and cellular longevity 2023 (2023)
Sevda Jafari, Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam, Ommoleila Molavi
Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. BioImpacts : BI 13 (1) (2022)
Leila Rostamizadeh, Ommoleila Molavi, Mohsen Rashid, Fatemeh Ramazani, Behzad Baradaran, Afsaneh Lavasanaifar, Raymond Lai
Recent advances in cancer immunotherapy: Modulation of tumor microenvironment by Toll-like receptor ligands. BioImpacts : BI 12 (3) (2022)
Sevda Jafari, Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam, Ommoleila Molavi
Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. BioImpacts : BI 13 (1) (2022)
Sevda Jafari, Afsaneh Lavasanifar, Mohammad Saied Hejazi, Nasrin Maleki-Dizaji, Mehran Mesgari, Ommoleila Molavi
STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 28 (1) (2020)
Sevda Jafari, Ommoleila Molavi, Houman Kahroba, Mohammad Saied Hejazi, Nasrin Maleki-Dizaji, Siamak Barghi, Seyed Hossein Kiaie, Farhad Jadidi-Niaragh
Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer. Cellular and molecular life sciences : CMLS 77 (19) (2020)
Mehdi A Vostakolaei, Ommoleila Molavi, Ghader Babaei, Ommoleila Molavi, Shirafkan Kordi, Jalal Abdolalizadeh
Hsp70 in cancer: A double agent in the battle between survival and death. Journal of cellular physiology 236 (5) (2020)
Ashkan H Rad, Farshid Asiaee, Sevda Jafari, Ali Shayanfar, Afsaneh Lavasanifar, Ommoleila Molavi
Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin. BioImpacts : BI 10 (2) (2019)

Ommoleila Molavi.css-eqlu8i{font-size:small;padding-left:4px;} (Leila Hatami-Baroogh)

Publication Activity (10 Years)

Top Topics

Top Venues

Ommoleila Molavi (Leila Hatami-Baroogh)